0001209191-19-049538.txt : 20190913 0001209191-19-049538.hdr.sgml : 20190913 20190913185827 ACCESSION NUMBER: 0001209191-19-049538 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190912 FILED AS OF DATE: 20190913 DATE AS OF CHANGE: 20190913 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROBIN SHERRINGTON CENTRAL INDEX KEY: 0001619962 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36687 FILM NUMBER: 191093466 MAIL ADDRESS: STREET 1: C/O XENON PHARMACEUTICALS INC. STREET 2: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: V5G4W8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xenon Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001582313 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980661854 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: V5G 48W BUSINESS PHONE: (604) 484-3300 MAIL ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: V5G 48W 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-09-12 0 0001582313 Xenon Pharmaceuticals Inc. XENE 0001619962 ROBIN SHERRINGTON 200 - 3650 GILMORE WAY BURNABY A1 BRITISH COLUMBIA, CANADA 0 1 0 0 EVP, Strategy & Innovation Common Shares 2019-09-12 4 M 0 6172 3.07 A 12064 D Common Shares 2019-09-12 4 F 0 1868 9.38 D 10196 D Stock Option (Right to Buy) 3.07 2019-09-12 4 M 0 6172 0.00 D 2019-09-18 Common Shares 6172 0 D The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise. Represents the closing price of the Company's common shares on September 11, 2019, which was converted to a Canadian dollar amount for purposes of net settlement calculations. The shares subject to the option fully vested on December 31, 2012. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3. /s/ Sherry Aulin, Attorney-in-fact 2019-09-13